For example, in the STEP 1 trial, the total proportion of lean mass in the participants at baseline was 53.9%
SEMAGLUTIDE RESULTS Reap the rewards as we progress with regular labs, feedback, and advanced technology to optimize your health and wellness
Health care professionals and consumers should report adverse events or side effects related to the use of this product to FDAs MedWatch Safety Information and Adverse Event Reporting Program: Complete and submit the report online at MedWatch Online Voluntary Reporting Form or Download and complete the form, then submit it via fax at 1-800-FDA-0178
Semaglutide supports significant weight loss in individuals who may have struggled with lifestyle changes alone by enhancing feelings of fullness, reducing appetite, and lowering overall food intake
Semaglutide can help reduce visceral fat, including stubborn belly fat, by supporting appetite control, improving insulin sensitivity, and encouraging fat loss rather than muscle loss
No approximation